Afro-immunoassay network
Welcome to the Afro-immunoassay network (AIA) page.
Afro Immuno Assay Network (AIA) started by AMANET in 2003, has been working on developing standardized immunological assays using standardized reagents and statistical tools to assess the association between acquisition of malaria specific antibody responses starting with four potential malaria vaccine candidate antigens and subsequent protection from clinical malaria. This is a concerted network of six African countries/institutions with different geographical and epidemiological settings comprising low to holo-endemic malaria and three supporting European institutions.
Under the European Malaria Vaccine Development Association (EMVDA) Integrated Project, the AIA network focuses on further standardization of immunological assays, for validation of malaria vaccine candiates currently in the pipeline and enhancement of relevant laboratory expertise required for these vaccines evaluation.
Call for letters of intent, Afro-immunoassay network phase two
The second phase of the the AIA network is about to start. Existing members from phase one with satisfactory performance as well as other African centres, including those with AMANET supported activities are welcomed to apply. Download the call on the link below.
Call for letters of intent [pdf, 26kb]
For additional and background information follow the links below:
Background of Afro-immunoassay network
Background Information AIA Phase 1 Members[pdf, 126kb]
The Second Phase AIA Generic Protocol [pdf, 97kb]
Reference standard coating steps for IgG and IgM and assay template[pdf, 33kb]
AIA References
Official Website of the EMVDA: www.emvda.org
Download the first EMVDA Newsletter [pdf, 206kb]
|
